L Rondahl

442 total citations
8 papers, 377 citations indexed

About

L Rondahl is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, L Rondahl has authored 8 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in L Rondahl's work include Peroxisome Proliferator-Activated Receptors (3 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). L Rondahl is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (3 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). L Rondahl collaborates with scholars based in Sweden, Slovakia and Canada. L Rondahl's co-authors include Tjeerd Barf, Thomas Lundbäck, J. Uppenberg, Eva Axén, Fredrik Lehmann, Stefan Svensson, Kristin Hammer, Július Brtko, Michal Uher and Rickard Westergren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry Letters and Heterocyclic Communications.

In The Last Decade

L Rondahl

7 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Rondahl Sweden 6 225 79 63 62 47 8 377
Eva Axén Sweden 9 201 0.9× 65 0.8× 37 0.6× 47 0.8× 26 0.6× 11 406
Colin J. Theobald United Kingdom 13 243 1.1× 142 1.8× 36 0.6× 32 0.5× 71 1.5× 18 464
Shi‐You Jiang China 8 194 0.9× 45 0.6× 47 0.7× 32 0.5× 73 1.6× 11 390
Juan José Mandoki Mexico 12 148 0.7× 97 1.2× 18 0.3× 55 0.9× 41 0.9× 28 481
Brian K. Adams United States 4 336 1.5× 139 1.8× 15 0.2× 73 1.2× 41 0.9× 7 571
Prakash C. Taunk United States 7 153 0.7× 33 0.4× 29 0.5× 42 0.7× 34 0.7× 12 258
André Stander South Africa 15 292 1.3× 114 1.4× 30 0.5× 58 0.9× 57 1.2× 34 506
Ann‐Kathrin Häfner Germany 14 212 0.9× 85 1.1× 23 0.4× 120 1.9× 55 1.2× 27 503
J Birnbaum United States 7 162 0.7× 52 0.7× 112 1.8× 48 0.8× 18 0.4× 14 455
Lena Schultz United States 11 363 1.6× 100 1.3× 19 0.3× 99 1.6× 45 1.0× 18 617

Countries citing papers authored by L Rondahl

Since Specialization
Citations

This map shows the geographic impact of L Rondahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Rondahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Rondahl more than expected).

Fields of papers citing papers by L Rondahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Rondahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Rondahl. The network helps show where L Rondahl may publish in the future.

Co-authorship network of co-authors of L Rondahl

This figure shows the co-authorship network connecting the top 25 collaborators of L Rondahl. A scholar is included among the top collaborators of L Rondahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Rondahl. L Rondahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Barf, Tjeerd, Fredrik Lehmann, Kristin Hammer, et al.. (2009). N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(6). 1745–1748. 96 indexed citations
2.
Xue, Yuan, Renhai Cao, Daniel Nilsson, et al.. (2008). FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proceedings of the National Academy of Sciences. 105(29). 10167–10172. 93 indexed citations
3.
Lehmann, Fredrik, Eva Axén, J. Uppenberg, et al.. (2004). Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorganic & Medicinal Chemistry Letters. 14(17). 4445–4448. 71 indexed citations
4.
Axén, Eva, et al.. (2004). Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(17). 4449–4452. 57 indexed citations
5.
Brtko, Július, L Rondahl, M Ficková, et al.. (2004). Kojic acid and its derivatives: history and present state of art.. PubMed. 12 Suppl. S16–8. 50 indexed citations
6.
Rondahl, L, Michal Uher, & Július Brtko. (2003). SYNTHESES AND STRUCTURE DETERMINATIONS OF SOME SELENOCYANATO- AND THIOCYANATO-KOJIC ACID DERIVATIVES. Heterocyclic Communications. 9(3). 257–258. 5 indexed citations
7.
Rondahl, L. (1980). Synthetic analogues of nicotine. VIII. Synthesis and biological testing of two tetrahydro-5-quinolinamines.. PubMed. 17(5). 288–91.
8.
Rondahl, L. (1977). Synthetic analogues of nicotine VI1,2. Nicotine substituted in the 5-position.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 113–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026